Additionally, the interaction with CD155 dynamically modulates DNAM-1 expression on the surface of NK cells, enabling certain tumor cells to evade DNAM-1-mediated immune surveillance through distinct immune escape mechanisms, ultimately resulting in unfavorable clinical outcomes [77]. Here, CD226 is linked to neoplasm.